Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: Comparison of different assays and evaluation of causes of discrepancies

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 11, 2012, Pages 3974-3982

  Latrofa, Francesco ^a   Ricci, Debora ^a   Montanelli, Lucia ^a   Rocchi, Roberto ^a   Piaggi, Paolo ^a   Sisti, Eleonora ^a   Grasso, Lucia ^a   Basolo, Fulvio ^a   Ugolini, Clara ^a   Pinchera, Aldo ^a   Vitti, Paolo ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; EPITOPE; THYROGLOBULIN ANTIBODY; THYROGLOBULIN ANTIBODY F(AB) A FRAGMENT; THYROGLOBULIN ANTIBODY F(AB) B FRAGMENT; THYROGLOBULIN ANTIBODY F(AB) C FRAGMENT; THYROGLOBULIN ANTIBODY F(AB) D FRAGMENT; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FOLLOW UP; HASHIMOTO DISEASE; HUMAN; INTERMETHOD COMPARISON; LYMPHOCYTIC THYROIDITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RADIOIMMUNOASSAY; REFERENCE VALUE; STANDARDIZATION;

ADULT; AUTOANTIBODIES; CARCINOMA; CARCINOMA, PAPILLARY; EPITOPES; FEMALE; HUMANS; MALE; MIDDLE AGED; THYROGLOBULIN; THYROID HORMONES; THYROID NEOPLASMS;

EID: 84868626627     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2406     Document Type: Article

References (42)

1. Latrofa F, Pinchera A 2008 Autoimmune hypothyroidism. In: Weetman AP, ed. Autoimmune diseases in endocrinology. Totowa, NJ: Humana Press Inc.; 136-174
2. Latrofa F, Ricci D, Vitti P, Prinzis A, Cambuli VM, Ghiani M, Pilia S, Carta D, Loche S, Pinchera A, Mariotti S 2010 Characterization of thyroglobulin epitopes in Sardinian adults and juveniles with Hashimoto's thyroiditis: evidence against a major effect of age and genetic background on B-cell epitopes. Clin Endocrinol (Oxf) 73:110-113
3. Pacini F, Mariotti S, Formica N, Elisei R, Anelli S, Capotorti E, Pinchera A 1988 Thyroid autoantibodies in thyroid cancer: incidence and relationship with tumour outcome. Acta Endocrinol (Copenh) 119:373-380
4. Rubello D, Casara D, Girelli ME, Piccolo M, Busnardo B 1992 Clinical meaning of circulating antithyroglobulin antibodies in differentiated thyroid-cancer - a prospective study. J Nucl Med 33:1478-1480
5. Kumar A, Shah DH, Shrihari U, Dandekar SR, Vijayan U, Sharma SM 1994 Significance of antithyroglobulin autoantibodies in differentiated thyroid carcinoma. Thyroid 4:199-202 (Pubitemid 24202356)
6. Mariotti S, Barbesino G, Caturegli P, Marinó M, Manetti L, Pacini F, Centoni R, Pinchera A 1995 Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal? J Clin Endocrinol Metab 80:468-472
7. Spencer CA, Takeuchi M, Kazarosyan M, Wang CC, Guttler RB, Singer PA, Fatemi S, LoPresti JS, Nicoloff JT 1998 Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 83:1121-1127 (Pubitemid 28496379)
8. Chiovato L, Latrofa F, Braverman LE, Pacini F, Capezzone M, Masserini L, Grasso L, Pinchera A 2003 Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med 139:346-351
9. Heilig B, Hüfner M, Dörken B, Schmidt-Gayk H 1986 Increased heterogeneity of serum thyroglobulin in thyroid cancer patients as determined by monoclonal antibodies. Klin Wochenschr 64:776-780 (Pubitemid 16044196)
10. Mazzaferri EL, Robbins RJ, Spencer CA, Braverman LE, Pacini F, Wartofsky L, Haugen BR, Sherman SI, Cooper DS, Braunstein GD, Lee S, Davies TF, Arafah BM, Ladenson PW, Pinchera A 2003 A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 88:1433-1441 (Pubitemid 36623351)
11. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787-803 (Pubitemid 43997716)
12. Cooper DS, Doherty GM, Haugen BR, Hauger BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214
13. Spencer CA, Lopresti JS 2008 Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer. Nat Clin Pract Endocrinol Metab 4:223-233 (Pubitemid 351430907)
14. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR 2003 Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13:3-126
15. McLachlan SM, Rapoport B 2004 Why measure thyroglobulin autoantibodies rather than thyroid peroxidase autoantibodies? Thyroid 14:510-520 (Pubitemid 39014589)
16. Kim WG, Yoon JH, Kim WB, Kim TY, Kim EY, Kim JM, Ryu JS, Gong G, Hong SJ, Shong YK 2008 Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 93:4683-4689
17. Tozzoli R, Bizzaro N, Tonutti E, Pradella M, Manoni F, Vilalta D, Bassetti D, Piazza A, Rizzotti P 2002 Immunoassay of anti-thyroid autoantibodies: high analytical variability in second generation methods. Clin Chem Lab Med 40:568-573 (Pubitemid 34855122)
18. Sapin R, d'Herbomez M, Gasser F, Meyer L, Schlienger JL 2003 Increased sensitivity of a new assay for anti-thyroglobulin antibody detection in patients with autoimmune thyroid disease. Clin Biochem 36:611-616 (Pubitemid 37434027)
19. Krahn J, Dembinski T 2009 Thyroglobulin and anti-thyroglobulin assays in thyroid cancer monitoring. Clin Biochem 42:416-419
20. Spencer CA, Bergoglio LM, Kazarosyan M, Fatemi S, LoPresti JS 2005 Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas. J Clin Endocrinol Metab 90:5566-5575 (Pubitemid 41415459)
21. Spencer C, Petrovic I, Fatemi S 2011 Current thyroglobulin autoantibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer. J Clin Endocrinol Metab 96:1283-1291
22. Latrofa F, Ricci D, Montanelli L, Rocchi R, Piaggi P, Sisti E, Grasso L, Basolo F, Ugolini C, Pinchera A, Vitti P 2012 Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin. J Clin Endocrinol Metab 97:2380-2387
23. Latrofa F, Pichurin P, Guo J, Rapoport B, McLachlan SM 2003 Thyroglobulin-thyroperoxidase autoantibodies are polyreactive, not bispecific: analysis using human monoclonal autoantibodies. J Clin Endocrinol Metab 88:371-378 (Pubitemid 36115191)
24. Latrofa F, Phillips M, Rapoport B, McLachlan SM 2004 Human monoclonal thyroglobulin autoantibodies: epitopes and immunoglobulin genes. J Clin Endocrinol Metab 89:5116-5123 (Pubitemid 39391458)
25. Latrofa F, Ricci D, Grasso L, Vitti P, Masserini L, Basolo F, Ugolini C, Mascia G, Lucacchini A, Pinchera A 2008 Characterization of thyroglobulin epitopes in patients with autoimmune and non-autoimmune thyroid diseases using recombinant human monoclonal thyroglobulin autoantibodies. J Clin Endocrinol Metab 93:591-596 (Pubitemid 351246677)
26. Jolliffe IT 2002 Principal component analysis. 2nd ed. New York: Springer-Verlag
27. Kaiser HF 1958 The varimax criterion for analytic rotation in factor analysis. Psychometrika 23:187-200
28. Latrofa F, Vitti P 2012 Diffuse and nodular goiter. In: Monaco F, editor. Thyroid diseases. Boca Raton, FL: Taylor and Francis Group; 9-47
29. Ott RA, McCall AR, McHenry C, Jarosz H, Armin A, Lawrence AM, Paloyan E 1987 The incidence of thyroid carcinoma in Hashimoto's thyroiditis. Am Surg 53:442-445 (Pubitemid 17122376)
30. Walker RP, Paloyan E 1990 The relationship between Hashimoto's thyroiditis, thyroid neoplasia, and primary hyperparathyroidism. Otolaryngol Clin North Am 23:291-302 (Pubitemid 20139194)
31. Rago T, Di Coscio G, Ugolini C, Scutari M, Basolo F, Latrofa F, Romani R, Berti P, Grasso L, Braverman LE, Pinchera A, Vitti P 2007 Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had a thyroidectomy. Clin Endocrinol (Oxf) 67:363-369 (Pubitemid 47283831)
32. Fiore E, Rago T, Scutari M, Ugolini C, Proietti A, Di Coscio G, Provenzale MA, Berti P, Grasso L, Mariotti S, Pinchera A, Vitti P 2009 Papillary thyroid cancer, although strongly associated with lymphocytic infiltration on histology, is only weakly predicted by serum thyroid auto-antibodies in patients with nodular thyroid diseases. J Endocrinol Invest 32:344-351
33. Spencer CA Clinical 2011 Utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC). J Clin Endocrinol Metab 96:3615-3627
34. Fiore E, Rago T, Latrofa F, Provenzale MA, Piaggi P, Delitala A, Scutari M, Basolo F, Di Coscio G, Grasso L, Pinchera A, Vitti P 2011 Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine. Endocr Relat Cancer 18:429-437
35. Utiger RD 1997 Follow-up of patients with thyroid carcinoma. N Engl J Med 337:928-930 (Pubitemid 27408578)
36. Schlumberger MJ 1998 Papillary and follicular thyroid carcinoma. N Engl J Med 338:297-306 (Pubitemid 28065257)
37. Schlumberger M, Catargi B, Borget I, Deandreis D, Zerdoud S, Bridji B, Bardet S, Leenhardt L, Bastie D, Schvartz C, Vera P, Morel O, Benisvy D, Bournaud C, Bonichon F, Dejax C, Toubert ME, Leboulleux S, Ricard M, Benhamou E 2012 Strategies of radioiodine ablation in patients with low-risk thyroid cancer. N Engl J Med 366:1663-1673
38. Mallick U, Harmer C, Yap B, Wadsley J, Clarke S, Moss L, Nicol A, Clark PM, Farnell K, McCready R, Smellie J, Franklyn JA, John R, Nutting CM, Newbold K, Lemon C, Gerrard G, Abdel-Hamid A, Hardman J, Macias E, Roques T, Whitaker S, Vijayan R, Alvarez P, Beare S, Forsyth S, Kadalayil L, Hackshaw A 2012 Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer. N Engl J Med 366:1674-1685
39. Algeciras-Schimnich A, Lasho MA, Ness KM, Cheryk LA, Grebe SK 2011 The Roche Elecsys and Siemens-Centaur thyroglobulin autoantibody assays show comparable clinical performance to the recently unavailable Beckman-Coulter access thyroglobulin autoantibody assay in identifying samples with potentially false-low thyroglobulin measurements due to thyroglobulin autoantibody interference. Thyroid 21:813-814
40. Taylor KP, Parkington D, Bradbury S, Simpson HL, Jefferies SJ, Halsall DJ 2011 Concordance between thyroglobulin antibody assays. Ann Clin Biochem 48:367-369
41. National Institute for Biological Standards and Control 2007 WHO reference reagent. Anti-thyroglobulin serum, human. NIBSC code: 65/093. Instructions for use (version 2.0, dated 26/11/2007). http://www.nibsc.ac.uk/ documents/ifu/65-093.pdf
42. Kim PS, Dunn AD, Dunn JT 1988 Altered immunoreactivity of thyroglobulin in thyroid disease. J Clin Endocrinol Metab 67:161-168